Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386560894> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4386560894 abstract "<p>Alu-NPs relay antitumor effects. <b>A,</b> Tumor growth curves for B16.F10 tumors treated intratumorally with 100 µL of either PBS or Alu-NPs at a 2 µg RNA dose (<i>n</i> = 4 or greater per treatment group). As indicated on the graph, treatments were administered three times every 3 days. The tumor growth curve for each treatment group was truncated to the first day in which a mouse in any treatment group reached the study endpoint. A two-way ANOVA with Sidak test was used for statistical analysis. *, <i>P</i> < 0.05; ***, <i>P</i> < 0.001; and ****, <i>P</i> < 0.0001. <b>B,</b> Total mouse weight over time for the mice with B16.F10 tumors. A two-way ANOVA with Sidak test was used for statistical analysis. <b>C,</b> Kaplan–Meier survival curve for the mice bearing B16.F10 tumors treated intratumorally with either PBS or Alu-NPs. log-rank (Mantel-C-ox) test was used for statistical analysis. <b>D,</b> Tumor growth curves for B16.F10 tumors treated as described in A with empty D-PDB NPs, edited Alu-NPs, or Alu-NPs. Edited Alu-NPs contain Alu RNA that is edited to be inactive (<i>n</i> = 7 per group). * represents <i>P</i> < 0.05 comparing Alu-NPs to PBS and D-PDB groups. <b>E,</b> Kaplan–Meier survival curve of mice treated with empty D-PDB NPs, edited Alu-NPs, or Alu-NPs. <b>F,</b> T-cell depletion was initiated with intraperitoneal injection of α-CD8 mAb (100 µg per injection) after tumor inoculation and before treatment. Alu-NPs were statistically different from PBS and Alu-NPs with α-CD8 treatment. Tumor growth curves for B16.F10 tumors after treatment as described in A in mice with or without CD8<sup>+</sup> T-cell depletion (<i>n</i> = 8–9 per group). Experiments in A–E were repeated twice and F was conducted once. * represents <i>P</i> < 0.05 comparing Alu-NPs with PBS and Alu-NPs + α-CD8 treated mice. Figure created with <a href=https://biorender.com target=_blank>biorender.com</a>.</p>" @default.
- W4386560894 created "2023-09-09" @default.
- W4386560894 creator A5006798929 @default.
- W4386560894 creator A5007263617 @default.
- W4386560894 creator A5026728364 @default.
- W4386560894 creator A5032619799 @default.
- W4386560894 creator A5037982412 @default.
- W4386560894 creator A5056838759 @default.
- W4386560894 date "2023-09-08" @default.
- W4386560894 modified "2023-10-16" @default.
- W4386560894 title "FIGURE 5 from Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy" @default.
- W4386560894 doi "https://doi.org/10.1158/2767-9764.24107107" @default.
- W4386560894 hasPublicationYear "2023" @default.
- W4386560894 type Work @default.
- W4386560894 citedByCount "0" @default.
- W4386560894 crossrefType "posted-content" @default.
- W4386560894 hasAuthorship W4386560894A5006798929 @default.
- W4386560894 hasAuthorship W4386560894A5007263617 @default.
- W4386560894 hasAuthorship W4386560894A5026728364 @default.
- W4386560894 hasAuthorship W4386560894A5032619799 @default.
- W4386560894 hasAuthorship W4386560894A5037982412 @default.
- W4386560894 hasAuthorship W4386560894A5056838759 @default.
- W4386560894 hasConcept C104317684 @default.
- W4386560894 hasConcept C10515644 @default.
- W4386560894 hasConcept C126322002 @default.
- W4386560894 hasConcept C141231307 @default.
- W4386560894 hasConcept C153911025 @default.
- W4386560894 hasConcept C197077220 @default.
- W4386560894 hasConcept C48931128 @default.
- W4386560894 hasConcept C54355233 @default.
- W4386560894 hasConcept C66339696 @default.
- W4386560894 hasConcept C71924100 @default.
- W4386560894 hasConcept C86803240 @default.
- W4386560894 hasConcept C99476002 @default.
- W4386560894 hasConceptScore W4386560894C104317684 @default.
- W4386560894 hasConceptScore W4386560894C10515644 @default.
- W4386560894 hasConceptScore W4386560894C126322002 @default.
- W4386560894 hasConceptScore W4386560894C141231307 @default.
- W4386560894 hasConceptScore W4386560894C153911025 @default.
- W4386560894 hasConceptScore W4386560894C197077220 @default.
- W4386560894 hasConceptScore W4386560894C48931128 @default.
- W4386560894 hasConceptScore W4386560894C54355233 @default.
- W4386560894 hasConceptScore W4386560894C66339696 @default.
- W4386560894 hasConceptScore W4386560894C71924100 @default.
- W4386560894 hasConceptScore W4386560894C86803240 @default.
- W4386560894 hasConceptScore W4386560894C99476002 @default.
- W4386560894 hasLocation W43865608941 @default.
- W4386560894 hasOpenAccess W4386560894 @default.
- W4386560894 hasPrimaryLocation W43865608941 @default.
- W4386560894 hasRelatedWork W129569737 @default.
- W4386560894 hasRelatedWork W19333003 @default.
- W4386560894 hasRelatedWork W1995917503 @default.
- W4386560894 hasRelatedWork W2060160990 @default.
- W4386560894 hasRelatedWork W2788292792 @default.
- W4386560894 hasRelatedWork W2890602474 @default.
- W4386560894 hasRelatedWork W3031268563 @default.
- W4386560894 hasRelatedWork W3136232645 @default.
- W4386560894 hasRelatedWork W4210863176 @default.
- W4386560894 hasRelatedWork W2360296623 @default.
- W4386560894 isParatext "false" @default.
- W4386560894 isRetracted "false" @default.
- W4386560894 workType "article" @default.